GLUE
#2362
Monte Rosa Therapeutics, Inc. - Common Stock
13.6 6 USD
-0.05%
Market Price
Secteur: Soins de Santé
Base: USD
Devise de Profit: USD
Range quotidien
Range Annuel
Changement quotidien
-4.61%
Changement Mensuel
-38.55%
Evolution sur 6 mois
-20.63%
Changement Annuel
+20.88%
Clôture Précédente
14.3 2
Open
13.6 7
Low
13.6 3
High
13.7 5
Volume
199
Financials
- Market Capitalization 1.17 B
- Employee 173
- Founded 2019
- CEO N/A
- Website www.monterosatx.com
- Headquarter Delaware, United States
- FIGI BBG00X2VGZQ3
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-33.72
ratio cours/chiffre d'affaires
10.53
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 2350 |  CRVS Corvus Pharmaceuticals, Inc. - Common Stock | 14.15 USD | -3.87% | -2.55% | +5.91% | +161.07% | 1.19 B USD | ||
| 2353 |  SANA Sana Biotechnology, Inc. - Common Stock | 3.96 USD | -3.18% | +2.59% | +20.73% | +30.69% | 1.19 B USD | ||
| 2380 |  KURA Kura Oncology, Inc. - Common Stock | 12.73 USD | -3.41% | +7.61% | +37.18% | +56.58% | 1.13 B USD | ||
| 2397 |  JANX Janux Therapeutics, Inc. - Common Stock | 18.18 USD | -3.19% | +3.89% | +21.85% | -21.30% | 1.11 B USD |